Published August 8, 2008 | Version v1
Journal article

Upregulation of decorin by FXR in vascular smooth muscle cells

  • 1. Department of Biochemistry and Molecular Biology, Third Military Medical University, Chongqing 400038 (China)
  • 2. Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 639 Salk Hall, Pittsburgh, PA 15261 (United States)
  • 3. Stem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213 (United States)

Description

Decorin is a member of the family of small leucine-rich proteoglycans that are present in blood vessels and synthesized by vascular smooth muscle cells (VSMCs). Decorin plays complex roles in both normal vascular physiology and the pathogenesis of various types of vascular disorders. However, the mechanisms of regulation of decorin expression in vasculature are not clearly understood. Particularly little information is available about a role of nuclear receptors in the regulation of decorin expression. In the present study, we report that activation of vascular FXR by a specific ligand resulted in upregulation of decorin at the levels of both mRNA and protein. FXR appears to induce decorin expression at a transcriptional level because (1) upregulation of decorin mRNA expression was abolished by the treatment of a transcription inhibitor, actinomycin D; and (2) decorin promoter activity was significantly increased by activation of FXR. Functional analysis of human decorin promoter identified an imperfect inverted repeat DNA motif, IR8 (-2313TGGTCAtagtgtcaTGACCT-2294), as a likely FXR-responsive element that is involved in decorin regulation

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2008.05.098

Additional details

Identifiers

DOI
10.1016/j.bbrc.2008.05.098;
PII
S0006-291X(08)01029-2;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
372
Journal Issue
4
Journal Page Range
p. 746-751
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.